Report overview
Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Based Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Based Gene Therapy. This report contains market size and forecasts of Nucleic Acid Based Gene Therapy in global, including the following market information:
Global Nucleic Acid Based Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nucleic Acid Based Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Anti-Sence and Anti-Gene Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nucleic Acid Based Gene Therapy include Wave Life Sciences, Imugene, Sarepta Therapeutics, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Moderna, BioNTech, Nutcracker Therapeutics and Deep Genomics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nucleic Acid Based Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Acid Based Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nucleic Acid Based Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Anti-Sence and Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Others
Global Nucleic Acid Based Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nucleic Acid Based Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Academic and Research Institutes
Others
Global Nucleic Acid Based Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nucleic Acid Based Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nucleic Acid Based Gene Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nucleic Acid Based Gene Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Wave Life Sciences
Imugene
Sarepta Therapeutics
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Moderna
BioNTech
Nutcracker Therapeutics
Deep Genomics
Sirnaomics
Laronde
Abogen Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nucleic Acid Based Gene Therapy, market overview.
Chapter 2: Global Nucleic Acid Based Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Nucleic Acid Based Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nucleic Acid Based Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
